Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp

<< Previous

Bullboard Posts

Next >>

Post by Roadappleson Aug 09, 2021 11:30am

152 Views

Post# 33671785

7 Key Takeaways From last ER

When compared to the same period last year, Canopy Growth recorded a 23% increase in total revenue. The growth was driven by increased sales of cannabis and other consumer packaged goods (CPG)
According to Canopy Growth’s internal proprietary market analytics platform, the company had the largest market share of Canada’s recreational cannabis market
Completed the acquisition of Ace Valley and Supreme Cannabis, and is focused on seamlessly integrating the assets
Canopy Growth has a large innovation pipeline with over 100+ SKUs across key product categories. The new products are expected to launch and be available between the second and the fourth quarter of 2022
The United States remains a major focus for Canopy Growth as it continues to increase brand awareness through broad portfolio of innovative cannabidiol (CBD) and CPG brands. The relationship with Martha Stewart is proving to be a growth driver for this aspect of the business
The management team reiterated its commitment to accelerating top-line growth in the second half of fiscal 2022 and achieving positive Adjusted EBITDA by end of fiscal 2022.
As of June 30th, Canopy Growth reported to have $2.1 billion of cash and short-term investments.